Difference between revisions of "Part:BBa K5237005"
(4 intermediate revisions by 3 users not shown) | |||
Line 45: | Line 45: | ||
<body> | <body> | ||
<!-- Part summary --> | <!-- Part summary --> | ||
− | <section | + | <section> |
<h1> | <h1> | ||
Half staple: TetR | Half staple: TetR | ||
</h1> | </h1> | ||
<p> | <p> | ||
− | The Tetracycline Repressor (tetR) is a bacterial transcriptional regulator that binds the tetO operon. | + | The Tetracycline Repressor (tetR) is a bacterial transcriptional regulator that binds the tetO operon. TetR can be |
readily fused with other DNA-binding proteins to form a functional staple for DNA-DNA proximity. We used this part | readily fused with other DNA-binding proteins to form a functional staple for DNA-DNA proximity. We used this part | ||
− | as a component of our simple staple (<a href="https://parts.igem.org/Part:BBa_K5237006">BBa_K5237006</a>) | + | as a component of our simple staple (<a href="https://parts.igem.org/Part:BBa_K5237006">BBa_K5237006</a>), and |
− | + | also fused it to | |
− | mNeonGreen | + | mNeonGreen as part of a FRET readout system (<a href="https://parts.igem.org/Part:BBa_K5237007">BBa_K5237007</a>). |
− | + | </p> | |
+ | <p> | ||
+ | <p> </p> | ||
</p> | </p> | ||
− | |||
</section> | </section> | ||
<div class="toc" id="toc"> | <div class="toc" id="toc"> | ||
Line 65: | Line 66: | ||
<ul> | <ul> | ||
<li class="toclevel-1 tocsection-1"><a href="#1"><span class="tocnumber">1</span> <span class="toctext">Sequence | <li class="toclevel-1 tocsection-1"><a href="#1"><span class="tocnumber">1</span> <span class="toctext">Sequence | ||
− | + | Overview</span></a> | |
</li> | </li> | ||
<li class="toclevel-1 tocsection-2"><a href="#2"><span class="tocnumber">2</span> <span class="toctext">Usage and | <li class="toclevel-1 tocsection-2"><a href="#2"><span class="tocnumber">2</span> <span class="toctext">Usage and | ||
Line 71: | Line 72: | ||
</li> | </li> | ||
<li class="toclevel-1 tocsetction-3"><a href="#3"><span class="tocnumber">3</span> <span class="toctext">Assembly | <li class="toclevel-1 tocsetction-3"><a href="#3"><span class="tocnumber">3</span> <span class="toctext">Assembly | ||
− | and | + | and Part Evolution</span></a> |
</li> | </li> | ||
<li class="toclevel-1 tocsection-5"><a href="#4"><span class="tocnumber">4</span> <span | <li class="toclevel-1 tocsection-5"><a href="#4"><span class="tocnumber">4</span> <span | ||
Line 77: | Line 78: | ||
<ul> | <ul> | ||
<li class="toclevel-2 tocsection-4"><a href="#4.1"><span class="tocnumber">4.1</span> <span | <li class="toclevel-2 tocsection-4"><a href="#4.1"><span class="tocnumber">4.1</span> <span | ||
− | class="toctext">Protein | + | class="toctext">Protein Expression and Mobility Shift Assay</span></a> |
</li> | </li> | ||
<li class="toclevel-2 tocsection-5"><a href="#4.2"><span class="tocnumber">4.2</span> <span | <li class="toclevel-2 tocsection-5"><a href="#4.2"><span class="tocnumber">4.2</span> <span | ||
class="toctext"><i>In Silico</i> Characterization using DaVinci</span></a> | class="toctext"><i>In Silico</i> Characterization using DaVinci</span></a> | ||
+ | </li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
Line 99: | Line 101: | ||
</div> | </div> | ||
</div> | </div> | ||
− | |||
<p> | <p> | ||
<br /> | <br /> | ||
− | + | While synthetic biology has in the past focused on engineering the genomic sequence of organisms, the <b>3D | |
− | regulation | + | spatial organization</b> of DNA is well-known to be an important layer of information encoding in |
− | cell fate, disease development and more. However, | + | particular in eukaryotes, playing a crucial role in |
− | + | gene regulation and hence | |
− | 3D genome in synthetic biology. We - iGEM Team Heidelberg 2024 - have developed PICasSO, a | + | cell fate, disease development, evolution, and more. However, tools to precisely manipulate and control the |
− | toolbox based on various DNA-binding proteins | + | genomic spatial |
+ | architecture are limited, hampering the exploration of | ||
+ | 3D genome engineering in synthetic biology. We - the iGEM Team Heidelberg 2024 - have developed PICasSO, a | ||
+ | <b>powerful | ||
+ | molecular toolbox for rationally engineering genome 3D architectures</b> in living cells, based on | ||
+ | various DNA-binding proteins. | ||
</p> | </p> | ||
<p> | <p> | ||
The <b>PICasSO</b> part collection offers a comprehensive, modular platform for precise manipulation and | The <b>PICasSO</b> part collection offers a comprehensive, modular platform for precise manipulation and | ||
− | re-programming | + | <b>re-programming |
− | + | of DNA-DNA interactions</b> using engineered "protein staples" in living cells. This enables | |
− | interactions, such as enhancer hijacking, or to design entirely new spatial architectures for gene regulation. | + | researchers to recreate naturally occurring alterations of 3D genomic |
− | Beyond its versatility, PICasSO includes robust assay systems to support the engineering, optimization, and | + | interactions, such as enhancer hijacking in cancer, or to design entirely new spatial architectures for |
− | testing of new staples | + | artificial gene regulation and cell function control. |
− | + | Specifically, the fusion of two DNA binding proteins enables to artificially bring otherwise distant genomic | |
+ | loci into | ||
+ | spatial proximity. | ||
+ | To unlock the system's full potential, we introduce versatile <b>chimeric CRISPR/Cas complexes</b>, | ||
+ | connected either at | ||
+ | the protein or - in the case of CRISPR/Cas-based DNA binding moieties - the guide RNA level. These complexes are | ||
+ | referred to as protein- or Cas staples, respectively. Beyond its | ||
+ | versatility with regard to the staple constructs themselves, PICasSO includes <b>robust assay</b> systems to | ||
+ | support the engineering, optimization, and | ||
+ | testing of new staples <i>in vitro</i> and <i>in vivo</i>. Notably, the PICasSO toolbox was developed in a | ||
+ | design-build-test-learn <b>engineering cycle closely intertwining wet lab experiments and computational | ||
+ | modeling</b> and iterated several times, yielding a collection of well-functioning and -characterized | ||
+ | parts. | ||
</p> | </p> | ||
<p>At its heart, the PICasSO part collection consists of three categories. <br /><b>(i)</b> Our <b>DNA-binding | <p>At its heart, the PICasSO part collection consists of three categories. <br /><b>(i)</b> Our <b>DNA-binding | ||
proteins</b> | proteins</b> | ||
include our | include our | ||
− | finalized | + | finalized Cas staple experimentally validated using an artificial "enhancer hijacking" system as well as |
− | new Cas staples in the future. We also include our Simple staples | + | "half staples" that can be combined by scientists to compose entirely |
− | and can be further engineered to create alternative, simpler and more compact staples. <br /> | + | new Cas staples in the future. We also include our Simple staples comprised of particularly small, simple |
− | <b>(ii)</b> As <b>functional elements</b>, we list additional parts that enhance the functionality of our Cas and | + | and robust DNA binding domains well-known to the synthetic biology community, which serve as controls for |
+ | successful stapling | ||
+ | and can be further engineered to create alternative, simpler, and more compact staples. <br /> | ||
+ | <b>(ii)</b> As <b>functional elements</b>, we list additional parts that enhance and expand the | ||
+ | functionality of our Cas and | ||
Basic staples. These | Basic staples. These | ||
− | consist of | + | consist of staples dependent on |
− | + | cleavable peptide linkers targeted by cancer-specific proteases or inteins that allow condition-specific, | |
− | + | dynamic stapling <i>in vivo</i>. | |
− | with our | + | We also include several engineered parts that enable the efficient delivery of PICasSO's constructs into |
+ | target cells, including mammalian cells, | ||
+ | with our new | ||
interkingdom conjugation system. <br /> | interkingdom conjugation system. <br /> | ||
− | <b>(iii)</b> As the final category of our collection, we provide parts that | + | <b>(iii)</b> As the final category of our collection, we provide parts that underlie our <b>custom |
readout | readout | ||
− | systems</b>. These include components of our established FRET-based proximity assay system, enabling users to | + | systems</b>. These include components of our established FRET-based proximity assay system, enabling |
+ | users to | ||
confirm | confirm | ||
− | accurate stapling. Additionally, we offer a complementary, application-oriented testing system | + | accurate stapling. Additionally, we offer a complementary, application-oriented testing system based on a |
− | + | luciferase reporter, which allows for straightforward experimental assessment of functional enhancer | |
+ | hijacking events | ||
in mammalian cells. | in mammalian cells. | ||
</p> | </p> | ||
Line 142: | Line 168: | ||
The following table gives a comprehensive overview of all parts in our PICasSO toolbox. <mark | The following table gives a comprehensive overview of all parts in our PICasSO toolbox. <mark | ||
style="background-color: #FFD700; color: black;">The highlighted parts showed | style="background-color: #FFD700; color: black;">The highlighted parts showed | ||
− | exceptional performance as described on our iGEM wiki and can serve as a reference.</mark> The other parts in | + | exceptional performance as described on our iGEM wiki and can serve as a reference.</mark> The other |
+ | parts in | ||
the | the | ||
− | collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer their | + | collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer |
− | own custom Cas staples, enabling further optimization and innovation.<br /> | + | their |
+ | own custom Cas staples, enabling further optimization and innovation in the new field of 3D genome | ||
+ | engineering.<br /> | ||
</p> | </p> | ||
<p> | <p> | ||
Line 151: | Line 180: | ||
</p> | </p> | ||
<table style="width: 90%; padding-right:10px;"> | <table style="width: 90%; padding-right:10px;"> | ||
− | <td align="left" colspan="3"><b>DNA- | + | <td align="left" colspan="3"><b>DNA-Binding Proteins: </b> |
− | + | Modular building blocks for engineering of custom staples to mediate defined DNA-DNA interactions <i>in vivo</i> | |
− | + | </td> | |
<tbody> | <tbody> | ||
<tr bgcolor="#FFD700"> | <tr bgcolor="#FFD700"> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237000" target="_blank">BBa_K5237000</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237000" target="_blank">BBa_K5237000</a></td> | ||
− | <td> | + | <td>Fusion Guide RNA Entry Vector MbCas12a-SpCas9</td> |
− | <td> | + | <td>Entry vector for simple fgRNA cloning via SapI</td> |
</tr> | </tr> | ||
<tr bgcolor="#FFD700"> | <tr bgcolor="#FFD700"> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237001" target="_blank">BBa_K5237001</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237001" target="_blank">BBa_K5237001</a></td> | ||
− | <td>Staple | + | <td>Staple Subunit: dMbCas12a-Nucleoplasmin NLS</td> |
− | <td>Staple subunit that can be combined with | + | <td>Staple subunit that can be combined with crRNA or fgRNA and dSpCas9 to form a functional staple |
+ | </td> | ||
</tr> | </tr> | ||
<tr bgcolor="#FFD700"> | <tr bgcolor="#FFD700"> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237002" target="_blank">BBa_K5237002</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237002" target="_blank">BBa_K5237002</a></td> | ||
− | <td>Staple | + | <td>Staple Subunit: SV40 NLS-dSpCas9-SV40 NLS</td> |
− | <td>Staple subunit that can be combined | + | <td>Staple subunit that can be combined with a sgRNA or fgRNA and dMbCas12a to form a functional staple |
</td> | </td> | ||
</tr> | </tr> | ||
Line 174: | Line 204: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237003" target="_blank">BBa_K5237003</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237003" target="_blank">BBa_K5237003</a></td> | ||
<td>Cas Staple: SV40 NLS-dMbCas12a-dSpCas9-Nucleoplasmin NLS</td> | <td>Cas Staple: SV40 NLS-dMbCas12a-dSpCas9-Nucleoplasmin NLS</td> | ||
− | <td>Functional Cas staple that can be combined with sgRNA or fgRNA to bring two DNA strands into close | + | <td>Functional Cas staple that can be combined with sgRNA and crRNA or fgRNA to bring two DNA strands into |
+ | close | ||
proximity | proximity | ||
</td> | </td> | ||
Line 180: | Line 211: | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237004" target="_blank">BBa_K5237004</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237004" target="_blank">BBa_K5237004</a></td> | ||
− | <td>Staple | + | <td>Staple Subunit: Oct1-DBD</td> |
<td>Staple subunit that can be combined to form a functional staple, for example with TetR.<br /> | <td>Staple subunit that can be combined to form a functional staple, for example with TetR.<br /> | ||
Can also be combined with a fluorescent protein as part of the FRET proximity assay</td> | Can also be combined with a fluorescent protein as part of the FRET proximity assay</td> | ||
Line 186: | Line 217: | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237005" target="_blank">BBa_K5237005</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237005" target="_blank">BBa_K5237005</a></td> | ||
− | <td>Staple | + | <td>Staple Subunit: TetR</td> |
<td>Staple subunit that can be combined to form a functional staple, for example with Oct1.<br /> | <td>Staple subunit that can be combined to form a functional staple, for example with Oct1.<br /> | ||
Can also be combined with a fluorescent protein as part of the FRET proximity assay</td> | Can also be combined with a fluorescent protein as part of the FRET proximity assay</td> | ||
Line 192: | Line 223: | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237006" target="_blank">BBa_K5237006</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237006" target="_blank">BBa_K5237006</a></td> | ||
− | <td>Simple | + | <td>Simple Staple: TetR-Oct1</td> |
<td>Functional staple that can be used to bring two DNA strands in close proximity</td> | <td>Functional staple that can be used to bring two DNA strands in close proximity</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237007" target="_blank">BBa_K5237007</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237007" target="_blank">BBa_K5237007</a></td> | ||
− | <td>Staple | + | <td>Staple Subunit: GCN4</td> |
<td>Staple subunit that can be combined to form a functional staple, for example with rGCN4</td> | <td>Staple subunit that can be combined to form a functional staple, for example with rGCN4</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237008" target="_blank">BBa_K5237008</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237008" target="_blank">BBa_K5237008</a></td> | ||
− | <td>Staple | + | <td>Staple Subunit: rGCN4</td> |
<td>Staple subunit that can be combined to form a functional staple, for example with rGCN4</td> | <td>Staple subunit that can be combined to form a functional staple, for example with rGCN4</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237009" target="_blank">BBa_K5237009</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237009" target="_blank">BBa_K5237009</a></td> | ||
− | <td>Mini | + | <td>Mini Staple: bGCN4</td> |
<td> | <td> | ||
Assembled staple with minimal size that can be further engineered</td> | Assembled staple with minimal size that can be further engineered</td> | ||
</tr> | </tr> | ||
</tbody> | </tbody> | ||
− | <td align="left" colspan="3"><b>Functional | + | <td align="left" colspan="3"><b>Functional Elements: </b> |
− | Protease-cleavable peptide linkers and inteins are used to control and modify staples for further optimization | + | Protease-cleavable peptide linkers and inteins are used to control and modify staples for further |
+ | optimization | ||
for custom applications</td> | for custom applications</td> | ||
<tbody> | <tbody> | ||
Line 219: | Line 251: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237010" target="_blank">BBa_K5237010</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237010" target="_blank">BBa_K5237010</a></td> | ||
<td>Cathepsin B-cleavable Linker: GFLG</td> | <td>Cathepsin B-cleavable Linker: GFLG</td> | ||
− | <td>Cathepsin B-cleavable peptide linker that can be used to combine two staple subunits to make responsive | + | <td>Cathepsin B-cleavable peptide linker that can be used to combine two staple subunits to make |
+ | responsive | ||
staples</td> | staples</td> | ||
</tr> | </tr> | ||
Line 225: | Line 258: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237011" target="_blank">BBa_K5237011</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237011" target="_blank">BBa_K5237011</a></td> | ||
<td>Cathepsin B Expression Cassette</td> | <td>Cathepsin B Expression Cassette</td> | ||
− | <td>Expression | + | <td>Expression cassette for the overexpression of cathepsin B</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237012" target="_blank">BBa_K5237012</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237012" target="_blank">BBa_K5237012</a></td> | ||
<td>Caged NpuN Intein</td> | <td>Caged NpuN Intein</td> | ||
− | <td>A caged NpuN split intein fragment that undergoes protein <i>trans</i>-splicing after protease | + | <td>A caged NpuN split intein fragment that undergoes protein <i>trans</i>-splicing after protease |
− | + | activation, which can be used to create functionalized staple | |
− | + | subunits</td> | |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237013" target="_blank">BBa_K5237013</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237013" target="_blank">BBa_K5237013</a></td> | ||
<td>Caged NpuC Intein</td> | <td>Caged NpuC Intein</td> | ||
− | <td>A caged NpuC split intein fragment that undergoes protein <i>trans</i>-splicing after protease | + | <td>A caged NpuC split intein fragment that undergoes protein <i>trans</i>-splicing after protease |
− | + | activation, which can be used to create functionalized staple | |
− | + | subunits</td> | |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237014" target="_blank">BBa_K5237014</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237014" target="_blank">BBa_K5237014</a></td> | ||
− | <td> | + | <td>Fusion Guide RNA Processing Casette</td> |
− | <td>Processing | + | <td>Processing cassette to produce multiple fgRNAs from one transcript, that can be used for |
− | genome | + | multiplexed 3D |
+ | genome reprogramming</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237015" target="_blank">BBa_K5237015</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237015" target="_blank">BBa_K5237015</a></td> | ||
<td>Intimin anti-EGFR Nanobody</td> | <td>Intimin anti-EGFR Nanobody</td> | ||
− | <td> | + | <td>Interkingdom conjugation between bacteria and mammalian cells, as an alternative delivery tool for |
+ | large | ||
constructs</td> | constructs</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><a href="https://parts.igem.org/Part:BBa_K4643003" target="_blank">BBa_K4643003</a></td> | ||
+ | <td>IncP Origin of Transfer</td> | ||
+ | <td>Origin of transfer that can be cloned into the plasmid vector and used for conjugation as a | ||
+ | means of | ||
+ | delivery</td> | ||
</tr> | </tr> | ||
</tbody> | </tbody> | ||
<td align="left" colspan="3"><b>Readout Systems: </b> | <td align="left" colspan="3"><b>Readout Systems: </b> | ||
− | FRET and enhancer recruitment to | + | FRET and enhancer recruitment readout systems to rapidly assess successful DNA stapling in bacterial and |
− | + | mammalian cells | |
+ | </td> | ||
<tbody> | <tbody> | ||
<tr bgcolor="#FFD700"> | <tr bgcolor="#FFD700"> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237016" target="_blank">BBa_K5237016</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237016" target="_blank">BBa_K5237016</a></td> | ||
<td>FRET-Donor: mNeonGreen-Oct1</td> | <td>FRET-Donor: mNeonGreen-Oct1</td> | ||
− | <td>FRET | + | <td>FRET donor-fluorophore fused to Oct1-DBD that binds to the Oct1 binding cassette, which can be used to |
+ | visualize | ||
DNA-DNA | DNA-DNA | ||
proximity</td> | proximity</td> | ||
Line 268: | Line 312: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237017" target="_blank">BBa_K5237017</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237017" target="_blank">BBa_K5237017</a></td> | ||
<td>FRET-Acceptor: TetR-mScarlet-I</td> | <td>FRET-Acceptor: TetR-mScarlet-I</td> | ||
− | <td>Acceptor part for the FRET assay binding the TetR binding cassette | + | <td>Acceptor part for the FRET assay binding the TetR binding cassette, which can be used to visualize |
+ | DNA-DNA | ||
proximity</td> | proximity</td> | ||
</tr> | </tr> | ||
Line 280: | Line 325: | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237019" target="_blank">BBa_K5237019</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237019" target="_blank">BBa_K5237019</a></td> | ||
<td>TetR Binding Cassette</td> | <td>TetR Binding Cassette</td> | ||
− | <td>DNA sequence containing 12 Oct1 binding motifs, can be used for different assays such as the FRET | + | <td>DNA sequence containing 12 Oct1 binding motifs, can be used for different assays such as the |
+ | FRET | ||
proximity assay</td> | proximity assay</td> | ||
</tr> | </tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237020" target="_blank">BBa_K5237020</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237020" target="_blank">BBa_K5237020</a></td> | ||
− | <td>Cathepsin B-Cleavable Trans-Activator: NLS-Gal4-GFLG-VP64</td> | + | <td>Cathepsin B-Cleavable <i>Trans</i>-Activator: NLS-Gal4-GFLG-VP64</td> |
− | <td>Readout system that responds to protease activity | + | <td>Readout system that responds to protease activity, which was used to test cathepsin B-cleavable linker |
− | + | </td> | |
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237021" target="_blank">BBa_K5237021</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237021" target="_blank">BBa_K5237021</a></td> | ||
<td>NLS-Gal4-VP64</td> | <td>NLS-Gal4-VP64</td> | ||
− | <td>Trans-activating enhancer, that can be used to simulate enhancer hijacking</td> | + | <td><i>Trans</i>-activating enhancer, that can be used to simulate enhancer hijacking</td> |
</tr> | </tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237022" target="_blank">BBa_K5237022</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237022" target="_blank">BBa_K5237022</a></td> | ||
− | <td>mCherry Expression Cassette: UAS, minimal | + | <td>mCherry Expression Cassette: UAS, minimal Promoter, mCherry</td> |
− | <td>Readout system for enhancer binding | + | <td>Readout system for enhancer binding, which was used to test cathepsin B-cleavable linker</td> |
− | + | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237023" target="_blank">BBa_K5237023</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237023" target="_blank">BBa_K5237023</a></td> | ||
− | <td>Oct1 - 5x UAS | + | <td>Oct1 - 5x UAS Binding Casette</td> |
<td>Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay</td> | <td>Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><a href="https://parts.igem.org/Part:BBa_K5237024" target="_blank">BBa_K5237024</a></td> | <td><a href="https://parts.igem.org/Part:BBa_K5237024" target="_blank">BBa_K5237024</a></td> | ||
− | <td>TRE-minimal | + | <td>TRE-minimal Promoter- Firefly Luciferase</td> |
− | <td>Contains | + | <td>Contains firefly luciferase controlled by a minimal promoter, which was used as a luminescence |
+ | readout for | ||
simulated enhancer hijacking</td> | simulated enhancer hijacking</td> | ||
</tr> | </tr> | ||
Line 327: | Line 373: | ||
<p> | <p> | ||
The tetracycline repressor protein (tetR) is naturally present in gram-negative bacteria and is involved in the | The tetracycline repressor protein (tetR) is naturally present in gram-negative bacteria and is involved in the | ||
− | resistance mechanism against tetracycline (and derivatives). It | + | resistance mechanism against tetracycline (and derivatives). It tightly controls gene expression |
of <i>tetA</i>, which encodes an efflux pump responsible for removing tetracycline from the cell. | of <i>tetA</i>, which encodes an efflux pump responsible for removing tetracycline from the cell. | ||
− | TetR binds selectively to two | + | TetR binds selectively to two palindromic recognition sequences (<i>tetO</i>>1,2) with high affinity. For DNA |
− | binding to occur | + | binding to occur TetR adopts a homodimeric structure and binds with two α-helix-turn-α-helix motifs |
− | (HTH) to two tandemly oriented tetO sequences. In the presence of tetracycline | + | (HTH) to two tandemly oriented tetO sequences. In the presence of tetracycline, TetR undergoes a |
− | conformational change, which prevents it from binding to DNA, | + | conformational change, which prevents it from binding to DNA, thereby allowing gene expression (Orth <i>et al.</i> |
2000; Kisker <i>et al.</i> 1995). | 2000; Kisker <i>et al.</i> 1995). | ||
<br /> | <br /> | ||
− | Due to its robust and highly regulatable DNA-binding properties, | + | Due to its robust and highly regulatable DNA-binding properties, TetR has become a widely adopted tool in |
synthetic | synthetic | ||
biology. Its ease of modification and ability to function in both prokaryotic and eukaryotic systems have made it | biology. Its ease of modification and ability to function in both prokaryotic and eukaryotic systems have made it | ||
an essential element in the development of gene regulation systems (Berens & Hillen, 2004). | an essential element in the development of gene regulation systems (Berens & Hillen, 2004). | ||
<br /> | <br /> | ||
− | + | Because of its well-characterized behavior, TetR was integrated into our design of a modular DNA-stapling system. | |
− | + | ||
</p> | </p> | ||
</section> | </section> | ||
<section id="3"> | <section id="3"> | ||
− | <h1>3. Assembly and | + | <h1>3. Assembly and Part Evolution</h1> |
<p>TetR was C-terminally fused to create a tetR-mScarlet-I-His<sub>6</sub>.</p> | <p>TetR was C-terminally fused to create a tetR-mScarlet-I-His<sub>6</sub>.</p> | ||
− | <p> | + | <p><!--Better formulation needed--> |
− | As part of developing a Förster Resonance Energy Transfer (FRET) | + | As part of developing a Förster Resonance Energy Transfer (FRET) assay, a modified version of TetR was |
− | created | + | created. |
− | + | Based on previous studies that successfully engineered single-chain TetR (scTetR) proteins with unaltered DNA | |
− | + | binding, we | |
+ | genetically fused two TetR proteins together with a flexible (G<sub>4</sub>S)<sub>6</sub> linker (Krueger <i>et | ||
al.</i> 2003; Zhou <i>et al.</i> 2007). | al.</i> 2003; Zhou <i>et al.</i> 2007). | ||
Unfortunately, under the T7 promoter system we tested, the expression levels were insufficient for further | Unfortunately, under the T7 promoter system we tested, the expression levels were insufficient for further | ||
Line 362: | Line 408: | ||
<h1>4. Results</h1> | <h1>4. Results</h1> | ||
<section id="4.1"> | <section id="4.1"> | ||
− | <h2>4.1 Protein | + | <h2>4.1 Protein Expression and Mobility Shift Assay</h2> |
<p> The fusion protein was expressed from a T7 based expression plasmid and subsequently | <p> The fusion protein was expressed from a T7 based expression plasmid and subsequently | ||
− | purified using metal affinity chromatography with Ni-NTA beads | + | purified using metal affinity chromatography with Ni-NTA beads (Fig. 1, left). |
DNA binding affinity in two different buffer systems was estimated with an electrophoretic mobility shift assay | DNA binding affinity in two different buffer systems was estimated with an electrophoretic mobility shift assay | ||
(EMSA) (Binding buffer 1: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2HPO4, 0.1 % (v/v) IGEPAL® CA-360, 1 | (EMSA) (Binding buffer 1: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2HPO4, 0.1 % (v/v) IGEPAL® CA-360, 1 | ||
− | mM | + | mM EDTA; Binding buffer 2: 10 mM Tris, 50 mM KCl). |
− | + | ||
<div class="thumb"> | <div class="thumb"> | ||
<div class="thumbinner" style="width:62%"> | <div class="thumbinner" style="width:62%"> | ||
Line 388: | Line 433: | ||
</div> | </div> | ||
<div class="thumbcaption" style="text-align: justify;"> | <div class="thumbcaption" style="text-align: justify;"> | ||
− | <i><b>Figure 2: Expression and DNA | + | <i><b>Figure 2: Expression and DNA Binding Analysis of tetR-mScarlet-I-His<sub>6</sub> Fusion |
− | + | Protein.</b></i><br /> | |
<i>Left image: SDS-PAGE analysis of protein expression. Lane 1: raw lysate of E. coli expression culture | <i>Left image: SDS-PAGE analysis of protein expression. Lane 1: raw lysate of E. coli expression culture | ||
after | after | ||
− | + | sterile filtration; Lane 2: Flow through of first wash; Lane 3: Flow | |
− | + | through of second wash; Lane 4: Elution of purified protein. | |
− | through | + | The expected band size of the protein is 50 737.60 Da, highlighted with a red box on the gel.<br /> |
− | + | Right image: Qualitative electrophoretic mobility shift assay of TetR in two different buffer systems. 1 | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | Right image: Qualitative electrophoretic mobility shift assay of | + | |
µM | µM | ||
− | protein and 0.5 µM DNA containing three | + | protein and 0.5 µM DNA containing three TetR binding sites were equilibrated in different buffer systems |
(Binding buffer 1: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2HPO4, 0.1 % (v/v) IGEPAL® CA-360, 1 | (Binding buffer 1: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2HPO4, 0.1 % (v/v) IGEPAL® CA-360, 1 | ||
mM | mM | ||
Line 416: | Line 456: | ||
<h2>4.2 <i>In Silico</i> Characterization using DaVinci</h2> | <h2>4.2 <i>In Silico</i> Characterization using DaVinci</h2> | ||
<p> | <p> | ||
− | We developed the in silico model <a href="https://2024.igem.wiki/heidelberg/model" target="_blank">DaVinci</a> | + | We developed the <i>in silico</i> model <a href="https://2024.igem.wiki/heidelberg/model" |
+ | target="_blank">DaVinci</a> | ||
for rapid engineering | for rapid engineering | ||
− | and development of our | + | and development of our PICasSO system. |
− | DaVinci acts as a digital twin to | + | DaVinci acts as a digital twin to PICasSO, designed to understand the forces acting on our system, |
refine experimental parameters, and find optimal connections between protein staples and target DNA. | refine experimental parameters, and find optimal connections between protein staples and target DNA. | ||
− | We calibrated DaVinci with literature and our own experimental affinity data | + | We calibrated DaVinci with literature and our own experimental affinity data calculated from EMSA assays with |
− | purified | + | purified proteins |
− | + | ||
− | + | ||
− | + | ||
DaVinci is divided into three phases: static structure prediction, all-atom dynamics simulation, and long-ranged | DaVinci is divided into three phases: static structure prediction, all-atom dynamics simulation, and long-ranged | ||
− | + | DNA | |
dynamics simulation. We applied the first two to our parts, characterizing structure and dynamics of the | dynamics simulation. We applied the first two to our parts, characterizing structure and dynamics of the | ||
− | + | DNA-binding interaction.<br /> | |
− | interaction. | + | The structures shown in Figure 4 were predicted using the AlphaFold server and the protein-DNA interaction |
+ | further | ||
+ | analyzed with all atom dynamics simulations. The depicted structures show favorable DNA binding, and no apparent | ||
+ | problems with the fusion protein and DNA binding were detected. | ||
</p> | </p> | ||
− | |||
<div class="thumb"> | <div class="thumb"> | ||
<div class="thumbinner" style="width:80%;"> | <div class="thumbinner" style="width:80%;"> | ||
− | <img alt=""src="" | + | <img alt="" class="thumbimage" src="https://static.igem.wiki/teams/5237/model/structure-figure-2-png.svg" |
− | + | style="width: 99%;" /> | |
<div class="thumbcaption"> | <div class="thumbcaption"> | ||
− | <i><b>Figure 4: | + | <i><b>Figure 4: Representations of the Simple Staple constructs</b> |
+ | Proteins are shown in full color (top row) and by their predicted structural accuracy during DNA | ||
+ | interaction. | ||
+ | The linkers were selected based on their structural property providing maximal flexibility. All structures | ||
+ | were predicted using the AlphaFold server (Google DeepMind, 2024).</i> | ||
+ | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
− | |||
</section> | </section> | ||
</section> | </section> | ||
− | <section id=" 5"> | + | <section id="5"> |
<h1>5. References</h1> | <h1>5. References</h1> | ||
<p>(Kisker et al., 1995; Krueger et al., 2003; Orth et al., 2000; Zhou et al., 2007)</p> | <p>(Kisker et al., 1995; Krueger et al., 2003; Orth et al., 2000; Zhou et al., 2007)</p> |
Latest revision as of 12:42, 2 October 2024
Half staple: TetR
The Tetracycline Repressor (tetR) is a bacterial transcriptional regulator that binds the tetO operon. TetR can be readily fused with other DNA-binding proteins to form a functional staple for DNA-DNA proximity. We used this part as a component of our simple staple (BBa_K5237006), and also fused it to mNeonGreen as part of a FRET readout system (BBa_K5237007).
Contents
While synthetic biology has in the past focused on engineering the genomic sequence of organisms, the 3D
spatial organization of DNA is well-known to be an important layer of information encoding in
particular in eukaryotes, playing a crucial role in
gene regulation and hence
cell fate, disease development, evolution, and more. However, tools to precisely manipulate and control the
genomic spatial
architecture are limited, hampering the exploration of
3D genome engineering in synthetic biology. We - the iGEM Team Heidelberg 2024 - have developed PICasSO, a
powerful
molecular toolbox for rationally engineering genome 3D architectures in living cells, based on
various DNA-binding proteins.
The PICasSO part collection offers a comprehensive, modular platform for precise manipulation and re-programming of DNA-DNA interactions using engineered "protein staples" in living cells. This enables researchers to recreate naturally occurring alterations of 3D genomic interactions, such as enhancer hijacking in cancer, or to design entirely new spatial architectures for artificial gene regulation and cell function control. Specifically, the fusion of two DNA binding proteins enables to artificially bring otherwise distant genomic loci into spatial proximity. To unlock the system's full potential, we introduce versatile chimeric CRISPR/Cas complexes, connected either at the protein or - in the case of CRISPR/Cas-based DNA binding moieties - the guide RNA level. These complexes are referred to as protein- or Cas staples, respectively. Beyond its versatility with regard to the staple constructs themselves, PICasSO includes robust assay systems to support the engineering, optimization, and testing of new staples in vitro and in vivo. Notably, the PICasSO toolbox was developed in a design-build-test-learn engineering cycle closely intertwining wet lab experiments and computational modeling and iterated several times, yielding a collection of well-functioning and -characterized parts.
At its heart, the PICasSO part collection consists of three categories.
(i) Our DNA-binding
proteins
include our
finalized Cas staple experimentally validated using an artificial "enhancer hijacking" system as well as
"half staples" that can be combined by scientists to compose entirely
new Cas staples in the future. We also include our Simple staples comprised of particularly small, simple
and robust DNA binding domains well-known to the synthetic biology community, which serve as controls for
successful stapling
and can be further engineered to create alternative, simpler, and more compact staples.
(ii) As functional elements, we list additional parts that enhance and expand the
functionality of our Cas and
Basic staples. These
consist of staples dependent on
cleavable peptide linkers targeted by cancer-specific proteases or inteins that allow condition-specific,
dynamic stapling in vivo.
We also include several engineered parts that enable the efficient delivery of PICasSO's constructs into
target cells, including mammalian cells,
with our new
interkingdom conjugation system.
(iii) As the final category of our collection, we provide parts that underlie our custom
readout
systems. These include components of our established FRET-based proximity assay system, enabling
users to
confirm
accurate stapling. Additionally, we offer a complementary, application-oriented testing system based on a
luciferase reporter, which allows for straightforward experimental assessment of functional enhancer
hijacking events
in mammalian cells.
The following table gives a comprehensive overview of all parts in our PICasSO toolbox. The highlighted parts showed
exceptional performance as described on our iGEM wiki and can serve as a reference. The other
parts in
the
collection are versatile building blocks designed to provide future iGEMers with the flexibility to engineer
their
own custom Cas staples, enabling further optimization and innovation in the new field of 3D genome
engineering.
Our part collection includes:
DNA-Binding Proteins: Modular building blocks for engineering of custom staples to mediate defined DNA-DNA interactions in vivo | ||
BBa_K5237000 | Fusion Guide RNA Entry Vector MbCas12a-SpCas9 | Entry vector for simple fgRNA cloning via SapI |
BBa_K5237001 | Staple Subunit: dMbCas12a-Nucleoplasmin NLS | Staple subunit that can be combined with crRNA or fgRNA and dSpCas9 to form a functional staple |
BBa_K5237002 | Staple Subunit: SV40 NLS-dSpCas9-SV40 NLS | Staple subunit that can be combined with a sgRNA or fgRNA and dMbCas12a to form a functional staple |
BBa_K5237003 | Cas Staple: SV40 NLS-dMbCas12a-dSpCas9-Nucleoplasmin NLS | Functional Cas staple that can be combined with sgRNA and crRNA or fgRNA to bring two DNA strands into close proximity |
BBa_K5237004 | Staple Subunit: Oct1-DBD | Staple subunit that can be combined to form a functional staple, for example with TetR. Can also be combined with a fluorescent protein as part of the FRET proximity assay |
BBa_K5237005 | Staple Subunit: TetR | Staple subunit that can be combined to form a functional staple, for example with Oct1. Can also be combined with a fluorescent protein as part of the FRET proximity assay |
BBa_K5237006 | Simple Staple: TetR-Oct1 | Functional staple that can be used to bring two DNA strands in close proximity |
BBa_K5237007 | Staple Subunit: GCN4 | Staple subunit that can be combined to form a functional staple, for example with rGCN4 |
BBa_K5237008 | Staple Subunit: rGCN4 | Staple subunit that can be combined to form a functional staple, for example with rGCN4 |
BBa_K5237009 | Mini Staple: bGCN4 | Assembled staple with minimal size that can be further engineered | Functional Elements: Protease-cleavable peptide linkers and inteins are used to control and modify staples for further optimization for custom applications |
BBa_K5237010 | Cathepsin B-cleavable Linker: GFLG | Cathepsin B-cleavable peptide linker that can be used to combine two staple subunits to make responsive staples |
BBa_K5237011 | Cathepsin B Expression Cassette | Expression cassette for the overexpression of cathepsin B |
BBa_K5237012 | Caged NpuN Intein | A caged NpuN split intein fragment that undergoes protein trans-splicing after protease activation, which can be used to create functionalized staple subunits |
BBa_K5237013 | Caged NpuC Intein | A caged NpuC split intein fragment that undergoes protein trans-splicing after protease activation, which can be used to create functionalized staple subunits |
BBa_K5237014 | Fusion Guide RNA Processing Casette | Processing cassette to produce multiple fgRNAs from one transcript, that can be used for multiplexed 3D genome reprogramming |
BBa_K5237015 | Intimin anti-EGFR Nanobody | Interkingdom conjugation between bacteria and mammalian cells, as an alternative delivery tool for large constructs |
BBa_K4643003 | IncP Origin of Transfer | Origin of transfer that can be cloned into the plasmid vector and used for conjugation as a means of delivery | Readout Systems: FRET and enhancer recruitment readout systems to rapidly assess successful DNA stapling in bacterial and mammalian cells |
BBa_K5237016 | FRET-Donor: mNeonGreen-Oct1 | FRET donor-fluorophore fused to Oct1-DBD that binds to the Oct1 binding cassette, which can be used to visualize DNA-DNA proximity |
BBa_K5237017 | FRET-Acceptor: TetR-mScarlet-I | Acceptor part for the FRET assay binding the TetR binding cassette, which can be used to visualize DNA-DNA proximity |
BBa_K5237018 | Oct1 Binding Casette | DNA sequence containing 12 Oct1 binding motifs, compatible with various assays such as the FRET proximity assay |
BBa_K5237019 | TetR Binding Cassette | DNA sequence containing 12 Oct1 binding motifs, can be used for different assays such as the FRET proximity assay | BBa_K5237020 | Cathepsin B-Cleavable Trans-Activator: NLS-Gal4-GFLG-VP64 | Readout system that responds to protease activity, which was used to test cathepsin B-cleavable linker |
BBa_K5237021 | NLS-Gal4-VP64 | Trans-activating enhancer, that can be used to simulate enhancer hijacking | BBa_K5237022 | mCherry Expression Cassette: UAS, minimal Promoter, mCherry | Readout system for enhancer binding, which was used to test cathepsin B-cleavable linker |
BBa_K5237023 | Oct1 - 5x UAS Binding Casette | Oct1 and UAS binding cassette, that was used for the simulated enhancer hijacking assay |
BBa_K5237024 | TRE-minimal Promoter- Firefly Luciferase | Contains firefly luciferase controlled by a minimal promoter, which was used as a luminescence readout for simulated enhancer hijacking |
1. Sequence overview
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 466
2. Usage and Biology
The tetracycline repressor protein (tetR) is naturally present in gram-negative bacteria and is involved in the
resistance mechanism against tetracycline (and derivatives). It tightly controls gene expression
of tetA, which encodes an efflux pump responsible for removing tetracycline from the cell.
TetR binds selectively to two palindromic recognition sequences (tetO>1,2) with high affinity. For DNA
binding to occur TetR adopts a homodimeric structure and binds with two α-helix-turn-α-helix motifs
(HTH) to two tandemly oriented tetO sequences. In the presence of tetracycline, TetR undergoes a
conformational change, which prevents it from binding to DNA, thereby allowing gene expression (Orth et al.
2000; Kisker et al. 1995).
Due to its robust and highly regulatable DNA-binding properties, TetR has become a widely adopted tool in
synthetic
biology. Its ease of modification and ability to function in both prokaryotic and eukaryotic systems have made it
an essential element in the development of gene regulation systems (Berens & Hillen, 2004).
Because of its well-characterized behavior, TetR was integrated into our design of a modular DNA-stapling system.
3. Assembly and Part Evolution
TetR was C-terminally fused to create a tetR-mScarlet-I-His6.
As part of developing a Förster Resonance Energy Transfer (FRET) assay, a modified version of TetR was created. Based on previous studies that successfully engineered single-chain TetR (scTetR) proteins with unaltered DNA binding, we genetically fused two TetR proteins together with a flexible (G4S)6 linker (Krueger et al. 2003; Zhou et al. 2007). Unfortunately, under the T7 promoter system we tested, the expression levels were insufficient for further experimental use. (More information can be found on our Wiki or the tetR-mScarlet-I composite part)
4. Results
4.1 Protein Expression and Mobility Shift Assay
The fusion protein was expressed from a T7 based expression plasmid and subsequently purified using metal affinity chromatography with Ni-NTA beads (Fig. 1, left). DNA binding affinity in two different buffer systems was estimated with an electrophoretic mobility shift assay (EMSA) (Binding buffer 1: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2HPO4, 0.1 % (v/v) IGEPAL® CA-360, 1 mM EDTA; Binding buffer 2: 10 mM Tris, 50 mM KCl).
4.2 In Silico Characterization using DaVinci
We developed the in silico model DaVinci
for rapid engineering
and development of our PICasSO system.
DaVinci acts as a digital twin to PICasSO, designed to understand the forces acting on our system,
refine experimental parameters, and find optimal connections between protein staples and target DNA.
We calibrated DaVinci with literature and our own experimental affinity data calculated from EMSA assays with
purified proteins
DaVinci is divided into three phases: static structure prediction, all-atom dynamics simulation, and long-ranged
DNA
dynamics simulation. We applied the first two to our parts, characterizing structure and dynamics of the
DNA-binding interaction.
The structures shown in Figure 4 were predicted using the AlphaFold server and the protein-DNA interaction
further
analyzed with all atom dynamics simulations. The depicted structures show favorable DNA binding, and no apparent
problems with the fusion protein and DNA binding were detected.
5. References
(Kisker et al., 1995; Krueger et al., 2003; Orth et al., 2000; Zhou et al., 2007)
Kisker, C., Hinrichs, W., Tovar, K., Hillen, W., & Saenger, W. (1995). The Complex Formed Between Tet Repressor and Tetracycline-Mg2+ Reveals Mechanism of Antibiotic Resistance. Journal of Molecular Biology, 247(2), 260–280. https://doi.org/10.1006/jmbi.1994.0138
Krueger, C., Berens, C., Schmidt, A., Schnappinger, D., & Hillen, W. (2003). Single-chain Tet transregulators. Nucleic Acids Research, 31(12), 3050–3056.
Orth, P., Schnappinger, D., Hillen, W., Saenger, W., & Hinrichs, W. (2000). Structural basis of gene regulation by the tetracycline inducible Tet repressor-operator system. Nature Structural Biology, 7(3), 215–219. https://doi.org/10.1038/73324
Zhou, X., Symons, J., Hoppes, R., Krueger, C., Berens, C., Hillen, W., Berkhout, B., & Das, A. T. (2007). Improved single-chain transactivators of the Tet-On gene expression system. BMC Biotechnology, 7, 6. https://doi.org/10.1186/1472-6750-7-6